. 2016 Oct 9;2:2055217316672100. doi: 10.1177/2055217316672100
© The Author(s) 2016
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Figure 1.
Duration of rituximab therapy.